Hatchtech gets lice treatment nod from FDA

02 August 2020

Read more from the Australian Financial Review below.

Learn more

Abbie Lewis

Author

Abbie Lewis

Abbie plays a key role in delivering OneVentures’ marketing, PR, community and branding initiatives, strengthening the firm’s identity and amplifying the visibility of our portfolio companies. Before joining OneVentures, Abbie worked at 89up in London, Europe’s first impact PR agency, where she contributed to global campaigns for NGOs.

You may also like

02 August 2020

Healthcare

FDA Approves Xeglyze™ for the topical treatment of head lice infestation


01 February 2018

OneVentures

No nit picking: Head lice group Hatchtech gets green light to trials


21 October 2014

OneVentures

Hatchtech announces successful results from Phase 2 ovicidal study


01 November 2013

OneVentures

Hatchtech gets new VC backing for lice treatment trial


View All